NCT00176488: Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer |
|
|
| Terminated | 2 | 31 | US | epirubicin, epirubicin hydrochloride, vinorelbine, vinorelbine ditartrate | University of Medicine and Dentistry of New Jersey, National Cancer Institute (NCI) | Breast Cancer | 10/09 | 10/09 | | |
